ArticleBMC pharmacology & toxicology2023

Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial.

Dawei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.